在NAFLD和NASH中Kupffer细胞的激活:机制和治疗干预措施
Gao-Xin Xu1, Song Wei1, Chao Yu1
1Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Frontiers in cell and developmental biology
|June 1, 2023
概括
库弗弗细胞 (KCs) 在非酒精性脂肪肝疾病 (NAFLD) 中驱动炎症. 了解KC功能为NAFLD和非酒精性脂肪肝炎 (NASH) 提供了新的治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 和非酒精性脂肪性肝炎 (NASH) 是全球慢性肝病的主要原因.
- 这些疾病可能会发展为肝硬化,肝癌和肝衰竭,肝移植是治疗末期纳氏血清性肝炎的唯一方法.
- 库弗弗细胞 (KCs),肝脏寄居的巨细胞,是先天免疫和疾病发病的关键参与者.
研究的目的:
- 审查了解NAFLD中Kupffer细胞 (KC) 生物学和免疫功能的最新进展.
- 探索KC与其他肝细胞的相互作用及其在疾病进展中的作用.
- 突出针对KCs在NAFLD和NASH预防和治疗方面的潜力.
主要方法:
- 文献综述,重点关注KC功能在NAFLD病变的发生.
- 分析涉及KCs的分子机制,信号通路和炎症反应.
- 综合了针对KCs的治疗干预信息.
主要成果:
- 凯基因被内源信号激活,释放炎症因子 (例如,NLRP3,TNF-α,IL-1β,IL-6),为炎症级联提供燃料.
- 与其他肝细胞的KC相互作用可以改善或恶化NAFLD的进展.
- 在过去五年中,在阐明KC特性,免疫功能和NAFLD治疗点方面取得了重大进展.
结论:
- 对NAFLD中KC机制的全面理解对于开发有效的预防和治疗策略至关重要.
- 准KC激活和炎症信号通路对管理NAFLD和NASH充满希望.
- 对KC特异性疗法的进一步研究可以减轻这些肝脏疾病日益增长的社会经济负担.
相关概念视频
Liver Regeneration
3.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
Chronic Pancreatitis II: Collaborative Care
117
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
117
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
717
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
717
Diseases of the Liver and Gallbladder
705
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
705
Liver Physiology
710
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
710


